Study summary
Padcev is a treatment for cancer in the bladder lining (urothelial cancer). Padcev is injected through a vein (known as an infusion). Padcev is now available in some countries in Europe.
People in this study will be adults with locally advanced (the cancer has spread to nearby tissue) or metastatic urothelial cancer. Metastatic means the cancer has spread to other parts of the body.
During their care, the person’s doctor will have prescribed Padcev treatment and other medicines to treat their cancer. People in the study will be treated according to their clinic’s standard practice. This study is about collecting information only. This study will survey people who know they are receiving Padcev treatment and have been given an information leaflet called a Patient Card.
The aim of the study is to check how well people understand the information on the Patient Card, including the risk of skin reactions that can be caused by Padcev treatment. Once a doctor has prescribed Padcev treatment, the patient (or their caregiver) will be asked if they would like to complete a survey. The survey will be completed on a computer and should take about 15 minutes to complete.
Study documents
Get more information
Would you like more information about clinical trial sites that are recruiting participants for A study to survey adults in Europe with cancer who receive Padcev? Contact us by filling out your information to the right and we’ll respond to you.
Locations
Frequently Asked Questions
While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.
Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.
In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.
Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.
Explore More


